RxDoctor Payments Data

Sunny Neal

Nurse Practitioner · Fredonia, KYNPI 1447805379

Payments from drug & device makers

$2,496in general payments, 2019–2025

Across 106 payments — averaging $23.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$701
  • AstraZeneca$575
  • Novo Nordisk$360
  • Amgen$200
  • Lilly USA, LLC$158
  • Agile Therapeutics, Inc.$115
  • plus $386 from 11 others

What the payments were for

  • Food & beverage$2,48299%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,496 in reported general payments places this provider in the 80th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide53$85,548
Breztri AerosphereBudesonide/Glycopyr/Formoterol30$45,658
MounjaroTirzepatide22$33,373
VraylarCariprazine Hcl20$30,805
TrulicityDulaglutide22$26,118
JanuviaSitagliptin Phosphate21$18,510
FarxigaDapagliflozin Propanediol14$16,455
JardianceEmpagliflozin12$15,308
EliquisApixaban12$10,402
Potassium Chloride51$4,657
Insulin Lispro Kwikpen U-100Insulin Lispro12$2,795
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$2,459
Ultra-Fine Micro Pen NeedlePen Needle, Diabetic16$1,604
Atorvastatin Calcium186$1,432
Ezetimibe24$1,334

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$360$85,54853 claims
AstraZenecaBreztri Aerosphere, Farxiga$575$62,11344 claims
Lilly USA, LLCMounjaro, Trulicity$158$59,49144 claims
AbbVieVraylar$701$30,80520 claims
Boehringer IngelheimJardiance$12$15,30812 claims
PfizerEliquis$47$10,40212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Fredonia

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →